Business Context and Reporting Period
This Form 8-K is filed by Xcyte Therapies, Inc. (not Bio Green Med Solution, Inc.) on November 11, 2004. The report announces financial results for the third quarter ended September 30, 2004. The registrant is incorporated in Delaware with principal executive offices in Seattle, Washington.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the attached press release (Exhibit 99.1), which is incorporated by reference but not reproduced in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that third-quarter results have been issued.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, or specific risk factors. It includes a standard disclaimer stating that the information in this Form 8-K and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference into any filing under the Securities Act of 1933, except as expressly set forth by specific reference.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net loss, cash position) by reviewing the attached Exhibit 99.1 (Press Release dated November 11, 2004).
- Confirm the discrepancy between the request metadata company name ("Bio Green Med Solution, Inc.") and the actual registrant ("Xcyte Therapies, Inc.").
- Review the full press release for any forward-looking statements or operational updates not summarized in this 8-K.